You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

calcitonin gene-related peptide (CGRP)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peptide (CGRP) as Biomarker of Migraine

Recruiting
  • Migraine
  • Nociceptive Blink Reflex
  • Greifswald, Germany
    University Medicine Greifswald
Mar 3, 2023

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Dry Eye, Asthenopia Trial in Torrance (Galcanezumab-gnlm, Ubrogepant)

    Recruiting
    • Dry Eye
    • Asthenopia
    • Torrance, California
      NVision-EWEI-Torrance
    May 31, 2023

    Migraine Trial in Tübingen (High frequency stimulation (HFS), Low-frequency sinusoidal transcutaneous stimulation (sLFS))

    Active, not recruiting
    • Migraine
    • High frequency stimulation (HFS)
    • Low-frequency sinusoidal transcutaneous stimulation (sLFS)
    • Tübingen, Germany
      University Hospital Tübingen
    May 17, 2022

    Migraine Trial in Copenhagen (Calcitonin Gene-Related Peptide, Erenumab)

    Recruiting
    • Migraine
    • Copenhagen, Glostrup, Denmark
      Danish Headache Center
    Oct 21, 2022

    Migraine, Migraine Without Aura, Migraine With Aura Trial in Glostrup (Erenumab, Placebo, Calcitonin gene-related peptide)

    Recruiting
    • Migraine
    • +2 more
    • Glostrup, Denmark
      Danish Headache Center
    Oct 6, 2020

    CGRP Expression in Human Periodontal Ligament Trial in Bucaramanga (Orthodontic forces)

    Completed
    • CGRP Expression in Human Periodontal Ligament
    • Orthodontic forces
    • Bucaramanga, Metropolitana, Colombia
      Universidad Santo Tomas
    May 10, 2021

    Effect of Drug, Migraine Disorders Trial in Kafr Ash Shaykh (Lacosamide 50 mg)

    Recruiting
    • Effect of Drug
    • Migraine Disorders
    • Lacosamide 50 mg
    • Kafr Ash Shaykh, Egypt
      Kafr Elsheikh University Hospital
    Nov 20, 2022

    New Daily Persistent Headache Biomarkers Study

    Terminated
    • New Daily Persistent Headache
    • New Daily Persistent Headache (NDPH)
      • Bronx, New York
        Montefiore Headache Center
      Feb 15, 2022

      Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)

      Active, not recruiting
      • Post Concussive Symptoms
      • Early intervention programme
      • Enhanced usual care
      • (no location specified)
      Apr 11, 2023

      Migraine Trial in Glostrup (Eptinezumab, PACAP-38)

      Recruiting
      • Migraine
      • Glostrup, Denmark
        Danish headache center
      Dec 1, 2022

      Post-Traumatic Headache, Concussion, Mild Trial in Glostrup (Calcitonin Gene-Related Peptide, Placebo)

      Completed
      • Post-Traumatic Headache
      • Concussion, Mild
      • Calcitonin Gene-Related Peptide
      • Placebo
      • Glostrup, Denmark
        Danish Headache Center
      Jan 27, 2020

      Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

      Recruiting
      • Migraine Disorders
      • +2 more
      • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
      • Pavia, Italy
        Headache Science & Neurorehabilitation Center
      Nov 23, 2023

      New Persistent Daily Headache Trial (CGRP antibody)

      Not yet recruiting
      • New Persistent Daily Headache
      • CGRP antibody
      • (no location specified)
      Aug 29, 2023

      Caused by Anti-CGRP mAbs in Migraine Patients Treated With

      Recruiting
      • Migraine Disorders
      • Diagnostic radiology
      • Lugano, Ticino, Switzerland
        Chiara ZECCA
      Sep 6, 2023

      CGRP Inhibition, Autonomic Function, and Migraine

      Recruiting
      • Episodic Migraine
      • Chronic Migraine
      • Vienna, Austria
        Medical University of Vienna
      Apr 8, 2022

      Migraine; Status Trial in Douliu (Acupressure elastic band (Sea-Band), General elastic band (no bud))

      Completed
      • Migraine; Status
      • Acupressure elastic band (Sea-Band)
      • General elastic band (no bud)
      • Douliu, Yunlin County, Taiwan
        National Taiwan University Hospital Yunlin Branch
      Jul 11, 2022

      Neuropeptides and Venous Pelvic Pain

      Active, not recruiting
      • Pelvic Pain
      • +2 more
        • Moscow, Russian Federation
          Department of Faculty Surgery №1
        Sep 20, 2021

        Opioid Analgesic Adverse Reaction Trial in Taiyuan (Esketamine, Sulfentanil or/and Remifentanil)

        Recruiting
        • Opioid Analgesic Adverse Reaction
        • Esketamine, Sulfentanil or/and Remifentanil
        • Taiyuan, Shanxi, China
          Zheng Guo
        Apr 18, 2022

        Migraine Trial in Glostrup (Calcitonin Gene Related Peptide, Sumatriptan 50 mg, Placebo Oral Tablet)

        Completed
        • Migraine
        • Calcitonin Gene Related Peptide
        • +2 more
        • Glostrup, Denmark
          Rigshospitalet Glostrup
        Sep 11, 2019

        Chronic Migraine, Headache Trial in Alexandria (Lidocaine IV)

        Active, not recruiting
        • Chronic Migraine, Headache
        • Lidocaine IV
        • Alexandria, Egypt
          Alexandria University,Medical Research Institute
        Oct 25, 2023

        Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

        Recruiting
        • Migraine
        • +4 more
        • Innsbruck, Tirol, Austria
        • +2 more
        Oct 19, 2022

        MIDAS Reduction at 3 Months for Erenumab Treatment

        Completed
        • Migraine
        • Erenumab 70/140 mg s.c.
        • Pavia, Italy
          Headache Science & Neurorehabilitation Center
        Jun 28, 2022

        Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

        Recruiting
        • Migraine Prophylaxis
        • Nicotinic Acid 500 MG Extended Release Oral Tablet
        • +2 more
        • Dhaka, Bangladesh
          BSMMU
        May 5, 2023